Evidence map›Paper›PMID 26883474›Full record

ArticleScientific reports2016

Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications.

Waseem Asghar, Mehmet Yuksekkaya, Hadi Shafiee, Michael Zhang, Mehmet O Ozen, Fatih Inci, Mustafa Kocakulak, Utkan Demirci

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Exosomal biomarkers for cancer diagnosis and patient monitoring.Expert review of molecular diagnostics · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Waseem AsgharBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Electrical Engineering Department (by courtesy), Stanford University, Palo Alto, CA 94304.
Mehmet YuksekkayaBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Division for Biomedical Engineering, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02139, USA.
Hadi ShafieeBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Division for Biomedical Engineering, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02139, USA.
Michael ZhangBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Division for Biomedical Engineering, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02139, USA.
Mehmet O OzenBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Electrical Engineering Department (by courtesy), Stanford University, Palo Alto, CA 94304.
Fatih InciBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Electrical Engineering Department (by courtesy), Stanford University, Palo Alto, CA 94304.
Mustafa KocakulakBaşkent University, Faculty of Engineering, Biomedical Engineering Department, Ankara, Turkey.
Utkan DemirciBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Electrical Engineering Department (by courtesy), Stanford University, Palo Alto, CA 94304.

Funding

Rapid Fluorescence-Based Determination of Antibiotic SusceptibilityU54EB015408 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI PARRISH, JOHN A, SCHACHTER, STEVEN · 2012 to 2022
$49.2M
Point-of-Care Rapid Blood Testing Using Microfluidic DevicesR01AI081534 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2009 to 2013
$2.1M
Novel disposable microchips for HIV-1 viral loadR01AI093282 · NIAID · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN · 2012 to 2015
$1.7M
Label-free HIV-1 Viral Load Measurement through a Contactless Electrode MicrochipF32AI102590 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAFIEE, HADI · 2013 to 2015
$171k
NIAID NIH HHS F32 AI102590NIAID NIH HHS F32AI102590NIAID NIH HHS R01 AI081534NIAID NIH HHS R01 AI093282NIBIB NIH HHS U54 EB015408NIBIB NIH HHS U54 EB015408-01
6 · The paper itself

Abstract

Although materials and engineered surfaces are broadly utilized in creating assays and devices with wide applications in diagnostics, preservation of these immuno-functionalized surfaces on microfluidic devices remains a significant challenge to create reliable repeatable assays that would facilitate patient care in resource-constrained settings at the point-of-care (POC), where reliable electricity and refrigeration are lacking. To address this challenge, we present an innovative approach to stabilize surfaces on-chip with multiple layers of immunochemistry. The functionality of microfluidic devices using the presented method is evaluated at room temperature for up to 6-month shelf life. We integrated the preserved microfluidic devices with a lensless complementary metal oxide semiconductor (CMOS) imaging platform to count CD4(+) T cells from a drop of unprocessed whole blood targeting applications at the POC such as HIV management and monitoring. The developed immunochemistry stabilization method can potentially be applied broadly to other diagnostic immuno-assays such as viral load measurements, chemotherapy monitoring, and biomarker detection for cancer patients at the POC.

Indexed as

Lab-On-A-Chip DevicesMicrofluidic Analytical TechniquesPoint-of-Care SystemsCD4 Lymphocyte CountHumans

Identifiers

PMID26883474
PMCPMC4756328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.